As of 2026-03-23, the EV/EBITDA ratio of KemPharm Inc (KMPH) is -6.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KMPH's latest enterprise value is 153.95 mil USD. KMPH's TTM EBITDA according to its financial statements is -23.90 mil USD. Dividing these 2 quantities gives us the above KMPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.5x - 8.6x | 8.0x |
| Forward P/E multiples | 10.2x - 13.7x | 12.2x |
| Fair Price | (5.69) - (4.61) | (5.63) |
| Upside | -197.9% - -179.3% | -196.9% |
| Date | EV/EBITDA |